Transcatheter Aortic Valve Replacement in Congenital Heart Disease

Betemariam Sharew1,2, Beka Bakhtadze1,2, Thomas Das1,2

  • 1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

JACC. Case Reports
|February 21, 2024
PubMed

Insights

Transcatheter aortic valve replacement is feasible and safe for congenital heart disease patients. This procedure offers a valuable option for lifelong management and as a bridge to recovery or further interventions.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Transcatheter aortic valve replacement (TAVR) is not a standard treatment for congenital aortic valve disease.
  • Congenital heart disease (CHD) presents unique challenges for aortic valve management.

Observation:

  • This study details a single-center experience with TAVR in patients diagnosed with congenital heart disease.
  • The focus is on evaluating the short-term outcomes and applicability of TAVR in this specific population.

Findings:

  • Transcatheter aortic valve replacement demonstrated short-term feasibility and safety in patients with congenital heart disease.
  • TAVR plays a potential role in the lifelong care of congenital aortic valve disease.
  • The procedure can serve as a bridge to recovery, future surgical interventions, or heart transplantation.

Implications:

  • TAVR may expand treatment options for adults with congenital heart disease and aortic valve issues.
  • This approach could improve long-term outcomes and quality of life for CHD patients.
  • Further research is warranted to establish TAVR's long-term efficacy in this population.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...